Research Roundup: HIV Crispr therapy, MPP COVID-19 pill agreement, BARDA influenza funding
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC applauds OSTP's AP3 annual report while acknowledging limitations as well as the significant funding and political will that will be required to achieve the objective it lays out.
As 2022 begins, GHTC is taking stock of the top global health R&D policy issues for the year ahead. Here are the top six topics GHTC will be tracking.
2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.